Pensatech Pharma

Activities: Pharmaceutical

Trending Articles

  1. FDA Form 483 flags falsified records and live bird infestation at Dabur India OTC plant A FDA inspection report issued in January 2026 has revealed widespread CGMP failures at Dabur India's Dadra and Nagar Haveli facility, including manipulated microbiology data,...
  2. Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    The DNA bottleneck: how synthetic manufacturing could unlock the next wave of gene editing therapies As gene-editing therapies evolve towards increasingly complex applications, 4basebio CEO Amy Walker (AW) tells Dr Kevin Robinson (KSR) how advances in scalable enzymatic DNA...
  4. CelLBxHealth and AstraZeneca sign Master Services Agreement The new contract establishes CelLBxHealth as a qualified service provider to AstraZeneca, allowing it to support drug discovery and development through CTC-powered analytics of...
  5. Vetter named Best Managed Company for seventh year in a row The CDMO was the only company to be awarded Platinum status, having been recognised for its strategic focus, economic success and sustainability targets

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all